Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Apr 19;13(1):6367.
doi: 10.1038/s41598-023-32942-5.

The impact of pharmaceutical form and simulated side effects in an open-label-placebo RCT for improving psychological distress in highly stressed students

Affiliations
Randomized Controlled Trial

The impact of pharmaceutical form and simulated side effects in an open-label-placebo RCT for improving psychological distress in highly stressed students

Alexander Winkler et al. Sci Rep. .

Abstract

Open-label placebo (OLP) may be utilized to reduce psychological distress. Yet, potential contextual effects have not been explored. We investigated the impact of pharmaceutical form and the simulation of side effects in a parallel group RCT (DRKS00030987). A sample of 177 highly stressed university students at risk of depression were randomly assigned by computer generated tables to a 1-week intervention with active or passive OLP nasal spray or passive OLP capsule or a no-treatment control group. After the intervention, groups differed significantly in depressive symptoms but not regarding other outcomes of psychological distress (stress, anxiety, sleep quality, somatization), well-being or treatment expectation. OLP groups benefitted significantly more compared to the no-treatment control group (d = .40), OLP nasal spray groups significantly more than the OLP capsule group (d = .40) and the active OLP group significantly more than the passive OLP groups (d = .42). Interestingly, before intervention, most participants, regardless of group assignment, believed that the OLP capsule would be most beneficial. The effectiveness of OLP treatments seems to be highly influenced by the symptom focus conveyed by the OLP rationale. Moreover, pharmaceutical form and simulation of side effects may modulate efficacy, while explicit treatment expectation seems to play a minor role.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Participant flow chart.
Figure 2
Figure 2
CeboXan Comfort OLP capsules and nasal spray presented as placebo without active ingredient for the treatment of psychological distress.
Figure 3
Figure 3
Experimental design.
Figure 4
Figure 4
Planned contrasts for change in depressive symptoms (M, SE; DASS-21) from pre- to post-intervention for all groups (contrast 1: all OLPs vs. natural history; contrast 2: OLP nasal spray (passive + active) vs. capsule; contrast 3: active OLP vs. passive OLP (nasal spray, capsule)).
Figure 5
Figure 5
Planned contrasts for change in stress symptoms (M, SE; PSS-10) from pre- to post-intervention for all groups (contrast 1: all OLPs vs. natural history; contrast 2: OLP nasal spray (passive + active) vs. capsule; contrast 3: active OLP vs. passive OLP (nasal spray, capsule)).
Figure 6
Figure 6
Course of treatment expectation (mean TEX-Q score) across OLP groups.

Similar articles

Cited by

References

    1. Stallman HM. Psychological distress in university students: A comparison with general population data. Aust. Psychol. 2010;45:249–257. doi: 10.1080/00050067.2010.482109. - DOI
    1. Bergdahl J, Bergdahl M. Perceived stress in adults: prevalence and association of depression, anxiety and medication in a Swedish population. Stress. Health. 2002;18:235–241. doi: 10.1002/smi.946. - DOI
    1. McCabe SE. Correlates of nonmedical use of prescription benzodiazepine anxiolytics: Results from a national survey of US college students. Drug Alcohol Depend. 2005;79:53–62. doi: 10.1016/j.drugalcdep.2004.12.006. - DOI - PMC - PubMed
    1. Koushede V, Ekholm O, Holstein BE, Andersen A, Hansen EH. Stress and use of over-the-counter analgesics: Prevalence and association among Danish 25 to 44-year-olds from 1994 to 2005. Int. J. Public Health. 2011;56:81–87. doi: 10.1007/s00038-010-0188-6. - DOI - PubMed
    1. Hofmeister EH, Muilenburg JL, Kogan L, Elrod SM. Over-the-counter stimulant, depressant, and nootropic use by veterinary students. J. Vet. Med. Educ. 2010;37:403–416. doi: 10.3138/jvme.37.4.403. - DOI - PubMed

Publication types